For asthma, the authors suggest that airway exposure to endotoxins inhibits the activation of NF-κB by the increase in the synthesis of its attenuator, enzyme A20, being this one therapeutic key target for asthma prevention (85). This evidence concerns the gene NFKB1 and asthma.